Your browser doesn't support javascript.
[SARS-CoV-2 protease: an excellent target to develop drugs against COVID-19]. / Cibler la protéase majeure du SARS-CoV-2 pour fabriquer un médicament efficace contre ce coronavirus.
Ladoux, Annie; Azoulay, Stéphane; Dani, Christian.
  • Ladoux A; Université Côte d'Azur, Institut de biologie Valrose, Faculté de médecine, 28 avenue Valombrose, 06107 Nice, France.
  • Azoulay S; Université Côte d'Azur, Institut de chimie de Nice, Faculté des sciences, 28 avenue Valrose, 06108 Nice, France.
  • Dani C; Université Côte d'Azur, Institut de biologie Valrose, Faculté de médecine, 28 avenue Valombrose, 06107 Nice, France.
Med Sci (Paris) ; 36(6-7): 555-558, 2020.
Article in French | MEDLINE | ID: covidwho-611701

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Pneumonia, Viral / Protease Inhibitors / Coronavirus Infections / Betacoronavirus Type of study: Observational study Limits: Humans Language: French Journal: Med Sci (Paris) Journal subject: Medicine Year: 2020 Document Type: Article Affiliation country: Medsci

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Pneumonia, Viral / Protease Inhibitors / Coronavirus Infections / Betacoronavirus Type of study: Observational study Limits: Humans Language: French Journal: Med Sci (Paris) Journal subject: Medicine Year: 2020 Document Type: Article Affiliation country: Medsci